Javascript must be enabled to continue!
Cyclodextrin based nanosponges for pharmaceutical use: A review
View through CrossRef
Abstract
Nanosponges are a novel class of hyper-crosslinked polymer based colloidal structures consisting of solid nanoparticles with colloidal sizes and nanosized cavities. These nano-sized colloidal carriers have been recently developed and proposed for drug delivery, since their use can solubilize poorly water-soluble drugs and provide prolonged release as well as improve a drug’s bioavailability by modifying the pharmacokinetic parameters of actives. Development of nanosponges as drug delivery systems, with special reference to cyclodextrin based nanosponges, is presented in this article. In the current review, attempts have been made to illustrate the features of cyclodextrin based nanosponges and their applications in pharmaceutical formulations. Special emphasis has been placed on discussing the methods of preparation, characterization techniques and applications of these novel drug delivery carriers for therapeutic purposes. Nanosponges can be referred to as solid porous particles having a capacity to load drugs and other actives into their nanocavity; they can be formulated as oral, parenteral, topical or inhalation dosage forms. Nanosponges offer high drug loading compared to other nanocarriers and are thus suitable for solving issues related to stability, solubility and delayed release of actives. Controlled release of the loaded actives and solubility enhancement of poorly water-soluble drugs are major advantages of nanosponge drug delivery systems.
Title: Cyclodextrin based nanosponges for pharmaceutical use: A review
Description:
Abstract
Nanosponges are a novel class of hyper-crosslinked polymer based colloidal structures consisting of solid nanoparticles with colloidal sizes and nanosized cavities.
These nano-sized colloidal carriers have been recently developed and proposed for drug delivery, since their use can solubilize poorly water-soluble drugs and provide prolonged release as well as improve a drug’s bioavailability by modifying the pharmacokinetic parameters of actives.
Development of nanosponges as drug delivery systems, with special reference to cyclodextrin based nanosponges, is presented in this article.
In the current review, attempts have been made to illustrate the features of cyclodextrin based nanosponges and their applications in pharmaceutical formulations.
Special emphasis has been placed on discussing the methods of preparation, characterization techniques and applications of these novel drug delivery carriers for therapeutic purposes.
Nanosponges can be referred to as solid porous particles having a capacity to load drugs and other actives into their nanocavity; they can be formulated as oral, parenteral, topical or inhalation dosage forms.
Nanosponges offer high drug loading compared to other nanocarriers and are thus suitable for solving issues related to stability, solubility and delayed release of actives.
Controlled release of the loaded actives and solubility enhancement of poorly water-soluble drugs are major advantages of nanosponge drug delivery systems.
Related Results
FORMULATION AND EVALUATION OF AMPHOTERICIN B LOADED NANOSPONGES FOR TOPICAL DELIVERY
FORMULATION AND EVALUATION OF AMPHOTERICIN B LOADED NANOSPONGES FOR TOPICAL DELIVERY
In this work, solvent evaporation was used to create nanosponges, which were then combined with Amphotericin B to create a gel. The Nanosponges formulations were made utilising the...
Preparation, physicochemical characterization, and In vivo evaluation of miconazole nitrate nanosponges for the treatment of systemic mycoses
Preparation, physicochemical characterization, and In vivo evaluation of miconazole nitrate nanosponges for the treatment of systemic mycoses
Miconazole is a Biopharmaceutics Classification System (BCS) class II drug, thus limiting its oral bioavailability. Nanosponges can improve the oral bioavailability of poorly solub...
Study on the Inclusion Mechanism of Sarafloxacin/β-cyclodextrin Inclusion Complex
Study on the Inclusion Mechanism of Sarafloxacin/β-cyclodextrin Inclusion Complex
Abstract
The purpose of this study is to explore the inclusion mechanism of sarafloxacin/β- cyclodextrin inclusion complex and explain the fundamental reasons for the impro...
Nanosponges by the oxo-Michael polyaddition of cyclodextrins as sorbents of water pollutants: the o-toluidine case
Nanosponges by the oxo-Michael polyaddition of cyclodextrins as sorbents of water pollutants: the o-toluidine case
AbstractHydrophilic cyclodextrin nanosponges were prepared by the oxo-Michael polyaddition in an aqueous solution at pH > 10 of α-, β-, and γ-cyclodextrin with 1,4-bisacryloylpi...
Identification of β -cyclodextrin inclusion complex by infrared spectroscopy
Identification of β -cyclodextrin inclusion complex by infrared spectroscopy
Fast and reliable identification of obtaining product is very important in the industrial technology of synthesis of pharmaceutical substances.
Objective - to study inclusion...
Simvastatin dengan Senyawa Turunan Β-Siklodextrin
Simvastatin dengan Senyawa Turunan Β-Siklodextrin
This study aims to determine the profile of the inclusion complex formed between simvastatin and β-cyclodextrin and its derivatives. To determine the level of stability and determi...
Preparation and Characterization of Flurbiprofen/β-Cyclodextrin Inclusion Complex
Preparation and Characterization of Flurbiprofen/β-Cyclodextrin Inclusion Complex
This study aims to ameliorate the water solubility of flurbiprofen by using β-cyclodextrin (β-CD). The drug/ligand 1:1 (M/M) stoichiometry was determined based on the effect of β-C...
Formulation and evaluation of lovastatin loaded nanosponges
Formulation and evaluation of lovastatin loaded nanosponges
Nanotechnology mediated drug delivery has been reported to enhance the drug efficacy, bioavailability, reduced toxicity and improve patient compliance by targeting the cells and ti...

